Agrow is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Mozambique mulls revised biosafety rules

The Mozambique government is considering altering its decree covering biosafety regulations, the USDA's Foreign Agricultural Service (FAS) reports. The country passed Decree 6/2007 but found limitations, which induced the Minister of Science and Technology to seek a complete review of the regulations (Agrow No 617, p 21). The results of the review, published two years ago, led to recommendations to create "an operational biosafety regulatory framework in Mozambique". In 2012, the pro-GMO NGO, the African Biosafety Network of Expertise, carried out its own review "to strengthen the liability and redress articles of the draft regulations". The FAS understands that the Ministry is mulling a revised decree based on the reviews and will decide later this month whether to approve their findings and suggestions. The government would need to ratify any Ministry move. Revision is required before the country can initiate field trials of GM crops for the first time, the FAS notes.

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG000673

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel